NCT03599427View on ClinicalTrials.gov

Added Value of Systemic Lidocaine on Postoperative Pain, Opiate Use and Nausea After Knee Arthroscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

June 30, 2019

Conditions
SurgeryPain, PostoperativeNausea, PostoperativeOpioid Use
Interventions
DRUG

systemic lidocaine

Systemic lidocaine is administrated at induction of anesthesia and at the end of surgery (1.5 mg/kg).

DRUG

Placebo

Placebo is administrated at induction of anesthesia and at the end of surgery (0.075 ml/kg)

Trial Locations (1)

9000

AZ Maria Middelares, Ghent

All Listed Sponsors
lead

Algemeen Ziekenhuis Maria Middelares

OTHER

NCT03599427 - Added Value of Systemic Lidocaine on Postoperative Pain, Opiate Use and Nausea After Knee Arthroscopy | Biotech Hunter | Biotech Hunter